Influence of macular pigment and melanin on incident early AMD in a white population

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 6, 2007, Pages 767-773

  Kanis, Martijn J ^a   Berendschot, Tos T J M ^b   van Norren, Dirk ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AMD; Antioxidant; Fundus reflectance; Macular pigment; Melanin

Indexed keywords

MELANIN; VISUAL PIGMENT;

ADULT; AGE; AGED; ARTICLE; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; EYE PHOTOGRAPHY; EYE PROTECTION; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; OPTICAL DENSITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION;

ANTIOXIDANTS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUTEIN; MACULA LUTEA; MACULAR DEGENERATION; MALE; MELANINS; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RETINAL PIGMENTS; XANTHOPHYLLS;

EID: 34249342268     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0478-0     Document Type: Article

References (55)

1. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257-293
2. Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134
3. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439-446
4. Berendschot TTJM, van Norren D (2005) On the age dependency of the macular pigment optical density. Exp Eye Res 81:602-609
5. Berendschot TTJM, Goldbohm RA, Klöpping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322-3326
6. Berendschot TTJM, Willemse-Assink JJM, Bastiaanse M, de Jong PTVM, van Norren D (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43:1928-1932
7. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PTVM, Klaver CC, Klein BE, Klein R (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39:367-374
8. Bito LZ, Matheny A, Cruickshanks KJ, Nondahl DM, Carino OB (1997) Eye color changes past early childhood-The Louisville Twin Study. Arch Ophthalmol 115:659-663
9. Bone RA, Landrum JT, Cains A (1992) Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 32:105-110
10. Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM (2000) Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 71:239-245
11. Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531-1535
12. Cho EY, Seddon JM, Rosner B, Willett WC, Hankinson SE (2004) Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 122:883-892
13. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE (1996) A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276:1147-1151
14. Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W (2006) Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: The POLA Study. Invest Ophthalmol Vis Sci 47:2329-2335
15. Delori FC, Burns SA (1996) Fundus reflectance and the measurement of crystalline lens density. J Opt Soc Am A 13:215-226
16. Delori FC, Gragoudas ES, Francisco R, Pruett RC (1977) Monochromatic ophthalmoscopy and fundus photography. The normal fundus. Arch Ophthalmol 95:861-868
17. DeMarco P, Pokorny J, Smith VC (1992) Full-spectrum cone sensitivity functions for X-chromosome-linked anomalous trichromats. J Opt Soc Am A 9:1465-1476
18. Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20:227-253
19. Friedman DS, O'Colmain B, Tomany SC, McCarty C, de Jong PTVM, Nemesure B, Mitchell P, Kempen J, Congdon N (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-572
20. Gale CR, Hall NF, Phillips DI, Martyn CN (2003) Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 44:2461-2465
21. Hammond BR Jr, Wooten BR, Snodderly DM (1996) Cigarette smoking and retinal carotenoids: Implications for age-related macular degeneration. Vision Res 36:3003-3009
22. Hammond BR Jr, Wooten BR, Snodderly DM (1997) Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A 14:1187-1196
23. Handelman GJ, Dratz EA, Reay CC, van Kuijk JG (1988) Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 29:850-855
24. Hofman A, Grobbee DE, Dejong PTVM, Vandenouweland FA (1991) Determinants of disease and disability in the elderly-the Rotterdam Elderly Study. Eur J Epidemiol 7:403-422
25. Hyman LG, Lilienfeld AM, Ferris FL III, Fine SL (1983) Senile macular degeneration: A case-control study. Am J Epidemiol 118:213-227
26. Jahn C, Wustemeyer H, Brinkmann C, Trautmann S, Mossner A, Wolf S (2005) Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 243:222-227
27. Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38:1802-1811
28. Klaver CC, Assink JJ, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, de Jong PTVM (2001) Incidence and progression rates of age-related maculopathy. The Rotterdam Study. Invest Ophthalmol Vis Sci 42:2237-2241
29. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PTVM (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study. Arch Ophthalmol 116:653-658
30. Klein R, Klein BE, Cruickshanks KJ (1999) The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18:371-389
31. Klein R, Klein BE, Jensen SC, Meuer SM (1997) The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 104:7-21
32. Klein R, Klein BE, Linton KL, DeMets DL (1993) The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137:190-200
33. Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: A possible role in protection from age-related macular degeneration. Adv Pharmacol 38:537-556
34. Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz-Sapuntzakis M, Palta M (1995) Serum antioxidants and age-related macular degeneration in a population- based case-control study. Arch Ophthalmol 113:1518-1523
35. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR (2001) Risk factors for age-related maculopathy-The Visual Impairment Project. Arch Ophthalmol 119:1455-1462
36. Mitchell P, Wang JJ, Smith W, Leeder SR (2002) Smoking and the 5-year incidence of age-related maculopathy-The Blue Mountains Eye Study. Arch Ophthalmol 120:1357-1363
37. Neelam K, O'Gorman N, Nolan J, O'donovan O, Wong HB, Eong KGA, Beatty S (2005) Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker photometry. Invest Ophthalmol Vis Sci 46:1023-1032
38. Sarna T (1992) Properties and function of the ocular melanin-a photobiophysical view. J Photochem Photobiol B 12:215-258
39. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. J Am Med Assoc 272:1413-1420
40. Seddon JM, Willett WC, Speizer FE, Hankinson SE (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. J Am Med Assoc 276:1141-1146
41. Sharpe LT, Stockman A, Knau H, Jägle H (1998) Macular pigment densities derived from central and peripheral spectral sensitivity differences. Vision Res 38:3233-3239
42. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PTVM (2001) Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108:697-704
43. Smith W, Mitchell P, Leeder SR (1996) Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 114:1518-1523
44. Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674-685
45. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660-673
46. Tamakoshi A, Yuzawa M, Matsui M, Uyama M, Fujiwara NK, Ohno Y (1997) Smoking and neovascular form of age related macular degeneration in late middle aged males: Findings from a case-control study in Japan. Br J Ophthalmol 81:901-904
47. van de Kraats J, Berendschot TTJM, van Norren D (1996) The pathways of light measured in fundus reflectometry. Vision Res 36:2229-2247
48. Van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PT (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. J Am Med Assoc 294:3101-3107
49. Van Leeuwen R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG, de Jong PTVM (2003) Grading of age-related maculopathy for epidemiological studies-Is digital imaging as good as 35-mm film? Ophthalmology 110:1540-1544
50. Van Leeuwen R, Klaver CCW, Vingerling JR, Hofman A, de Jong PTVM (2003) The risk and natural course of age-related maculopathy-Follow-up at 61/ 2 years in the Rotterdam study. Arch Ophthalmol 121:519-526
51. van Norren D, van de Kraats J (1989) Retinal densitometer with the size of a fundus camera. Vision Res 29:369-374
52. Vinding T, Appleyard M, Nyboe J, Jensen G (1992) Risk factor-analysis for atrophic and exudative age-related macular degeneration-an Epidemiologic-Study of 1000 aged individuals. Acta Ophthalmol 70:66-72
53. Vingerling JR, Hofman A, Grobbee DE, de Jong PTVM (1996) Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 114:1193-1196
54. Weiter JJ, Delori FC, Wing GL, Fitch KA (1985) Relationship of senile macular degeneration to ocular pigmentation. Am J Ophthalmol 99:185-187
55. Weiter JJ, Delori FC, Wing GL, Fitch KA (1986) Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 27:145-152